JG
TMO icon

Jefferies Group’s Thermo Fisher Scientific TMO Stock Holding History

Jefferies Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,200
Closed -$6.14M – 1934
2021
Q4 		$6.14M Buy
+9,200
New +$5.74M 0.04% 404
2021
Q1 		– Sell
-1,300
Closed -$606K – 1994
2020
Q4 		$606K Hold
1,300
– – ﹤0.01% 1076
2020
Q3 		$574K Hold
1,300
– – 0.01% 950
2020
Q2 		$471 Sell
1,300
-4,000
-75% -$1.34M 0.01% 925
2020
Q1 		$1.5M Sell
5,300
-51,500
-91% -$16.2M 0.02% 810
2019
Q4 		$18.5M Buy
56,800
+56,700
+56,700% +$17.2M 0.14% 123
2019
Q3 		$29K Sell
100
-8,400
-99% -$2.41M ﹤0.01% 2613
2019
Q2 		$2.5M Sell
8,500
-3,800
-31% -$1.05M 0.02% 802
2019
Q1 		$3.37M Buy
12,300
+3,100
+34% +$771K 0.03% 616
2018
Q4 		$2.06M Buy
9,200
+1,900
+26% +$446K 0.02% 809
2018
Q3 		$1.78M Buy
7,300
+6,700
+1,117% +$1.54M 0.01% 1037
2018
Q2 		$124K Sell
600
-16,000
-96% -$3.4M ﹤0.01% 2106
2018
Q1 		$3.43M Buy
16,600
+7,600
+84% +$1.6M 0.02% 621
2017
Q4 		$1.71M Buy
9,000
+3,500
+64% +$671K 0.01% 1077
2017
Q3 		$1.04M Buy
5,500
+3,000
+120% +$543K 0.01% 1272
2017
Q2 		$436K Sell
2,500
-4,600
-65% -$773K ﹤0.01% 1668
2017
Q1 		$1.09M Buy
7,100
+4,000
+129% +$611K 0.01% 1231
2016
Q4 		$437K Sell
3,100
-4,800
-61% -$708K ﹤0.01% 1640
2016
Q3 		$1.26M Buy
7,900
+1,900
+32% +$293K 0.01% 1172
2016
Q2 		$887K Sell
6,000
-2,300
-28% -$339K ﹤0.01% 1193
2016
Q1 		$1.18M Buy
8,300
+4,100
+98% +$549K 0.01% 1072
2015
Q4 		$596K Buy
+4,200
New +$560K ﹤0.01% 1443
2015
Q3 		– Sell
-12,000
Closed -$1.56M – 3011
2015
Q2 		$1.56M Buy
12,000
+1,200
+11% +$156K 0.01% 1043
2015
Q1 		$1.45M Buy
10,800
+100
+0.9% +$12.9K 0.01% 893
2014
Q4 		$1.34M Buy
+10,700
New +$1.3M 0.01% 860
2014
Q2 		– Sell
-319,500
Closed -$38.4M – 2381
2014
Q1 		$38.4M Buy
+319,500
New +$38M 0.37% 39

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group's TMO Position: Q3 2022 in Review

Jefferies Group increased its Thermo Fisher Scientific (TMO) stake by 24% in Q3 2022, buying an estimated $5.2M and bringing the position to 48,688 shares worth $24.7M. The position accounts for 0.21% of the portfolio, ranked #74.

Jefferies Group first reported a position in TMO in Q2 2013 and has held it in 36 quarters since. The position peaked at $27.6M in Q1 2022. 2,266 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

  • Jefferies Group held 48,688 shares of Thermo Fisher Scientific worth $24.7M as of Q3 2022.
  • Jefferies Group bought 9,295 Thermo Fisher Scientific shares in Q3 2022, an estimated $5.2M.
  • Thermo Fisher Scientific made up 0.21% of Jefferies Group's portfolio in Q3 2022, its #74 holding.
  • Jefferies Group first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 36 quarters since.
  • Jefferies Group's Thermo Fisher Scientific position peaked at $27.6M in Q1 2022.
  • 2,266 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.